Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc (VIR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Lilly (LLY) Gets FDA Nod for Expanded Use of COVID Cocktail

FDA revises Lilly's (LLY) EUA for COVID-19 antibody cocktail, bamlanivimab and etesevimab, for post-exposure prophylaxis for COVID-19.

REGN : 651.88 (-0.20%)
GSK : 38.93 (-0.46%)
LLY : 230.10 (-0.41%)
VIR : 54.54 (+3.67%)
Vir Biotechnology to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that George Scangos, Ph.D., chief executive officer, will participate in a virtual fireside chat at the Morgan Stanley 19 Annual Global Healthcare...

VIR : 54.54 (+3.67%)
Vir Biotechnology to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Howard Horn, chief financial officer, is scheduled to present at the H.C. Wainwright 23 Annual Global Investment Conference on Monday, Sept. 13,...

VIR : 54.54 (+3.67%)
Will Regeneron's (REGN) Antibody Cocktail Fuel Further Growth?

Regeneron's (REGN) performance in the year has gained from higher demand for its antibody cocktail - REGEN-COV.

REGN : 651.88 (-0.20%)
GSK : 38.93 (-0.46%)
RHHBY : 46.0700 (-1.60%)
VIR : 54.54 (+3.67%)
Regeneron (REGN) COVID-19 Antibody Cocktail Gets CMA in the UK

Regeneron (REGN) gets Conditional Marketing Authorization for its antibody cocktail, casirivimab and imdevimab for COVID-19 infection in the United Kingdom.

REGN : 651.88 (-0.20%)
GSK : 38.93 (-0.46%)
RHHBY : 46.0700 (-1.60%)
VIR : 54.54 (+3.67%)
Vir Biotechnology Announces First Marketing Authorization for its First Commercial Product, Sotrovimab, Granted in Australia

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the first marketing authorization, granted in Australia, for its first commercial product, sotrovimab, developed in partnership with GlaxoSmithKline...

VIR : 54.54 (+3.67%)
Regeneron (REGN) Antibody Cocktail for COVID-19 Gets a Boost

Regeneron (REGN) antibody cocktail for COVID-19 receives a boost as the Governor of Florida recommends it for COVID-19 treatment.

REGN : 651.88 (-0.20%)
GSK : 38.93 (-0.46%)
LLY : 230.10 (-0.41%)
VIR : 54.54 (+3.67%)
Vir Biotechnology, Inc. (VIR) Q2 Earnings and Revenues Beat Estimates

Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of 167.65% and 205.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?...

VIR : 54.54 (+3.67%)
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the second quarter ended June 30, 2021.

VIR : 54.54 (+3.67%)
Eli Lilly (LLY) Q2 Earnings Miss, Sales Beat, Stock Down

Eli Lilly (LLY) reports mixed second-quarter results and ttightens 2021 sales forecast. Stock down in pre-market trading.

GSK : 38.93 (-0.46%)
LLY : 230.10 (-0.41%)
INCY : 75.99 (+1.27%)
VIR : 54.54 (+3.67%)

Barchart Exclusives

US Stock Markets: Stop the Seasonal Madness
A popular theme on financial television these days is September is a seasonally bearish time for US stock markets. The evidence does not support this idea. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar